LSL Pharma Group Acquires Virage Santé

Bain Capital and Cinven to Acquire Lonza Specialty Ingredients

February 8, 2021

Manufacturing

Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients (LSI), a division of Lonza AG, for a total enterprise value of CHF 4.2 billion. LSI, headquartered in Basel, Switzerland, is a global provider of specialty chemicals for microbial control with ~2,800 employees, and the consortium intends to invest in R&D, bolster production capabilities and use LSI as a platform for buy-and-build consolidation in the sector; the transaction was expected to close in H2 2021.

Spire Healthcare Group plc Acquires Vita Health Group Limited

October 20, 2023

Healthcare Services

Spire Healthcare Group plc has acquired Vita Health Group Limited for a net cash consideration of approximately £74 million. Vita, a leading UK provider of NHS outpatient mental health talking therapies, musculoskeletal and occupational health services with c.1,600 employees and forecast 2024 revenue >£100m, was sold by funds advised or managed by ARCHIMED and certain current and former employee shareholders.

Andlauer Healthcare Group Acquires Logistics Support Unit (LSU) Inc.

March 1, 2022

Logistics & Distribution

Andlauer Healthcare Group Inc. (AHG) has completed its acquisition of 100% of Logistics Support Unit (LSU) Inc. for approximately $30 million, paid via the issuance of 154,639 subordinate voting shares and about $22.5 million in cash. LSU is a Canada-based third-party logistics provider specializing in pharmaceutical, medical and biotechnology warehousing, distribution and order management and is the exclusive distributor of immunizing agents for Québec's public health system.

Lupin Healthcare Acquires Renascience Pharma Limited (UK)

April 2, 2025

Pharmaceuticals

Lupin Healthcare (UK) Limited, a wholly owned subsidiary of Lupin Limited, has acquired UK-based Renascience Pharma Limited, the sole supplier of four specialty branded products in the UK. The acquisition (reported at approximately £12.3 million) expands Lupin's branded specialty portfolio in the UK and strengthens its supply offerings to the NHS across infectious disease, ENT and cardiology/renal indications.

Highlander Partners Acquires Majority Stake in SanoVita

February 19, 2020

Food & Beverage

Highlander Partners, a Dallas-based middle-market private equity firm, has acquired a majority stake in SanoVita, a Romanian plant-based food brand headquartered in Râmnicu Vâlcea. Highlander plans to accelerate SanoVita's growth through new product innovation, enhanced production capabilities and strategic M&A while the founders will remain partners in the business.

Linden Capital Partners Acquires LifeStyles Healthcare

December 1, 2022

Consumer Products

Linden Capital Partners has acquired LifeStyles Healthcare, a global sexual health and wellness platform, from a consortium of investors including Trustar Capital and Humanwell Healthcare. The deal excludes LifeStyles' Chinese operations (including the Jissbon brand), which will be retained by the selling shareholders; Linden has named Laurent Faracci as incoming CEO and Ron Fugate as Chairman to drive commercial, brand, and innovation-led growth.